Team

The Atelerix Life Sciences Team is experienced in small molecule bio-technology, and has the drive to bring new drugs to market

Board of Directors

David Kalergis, MBA/JD
Founder & CEO

  • Founder & Former CEO of Diffusion Pharmaceuticals Inc., a publicly-traded small molecule biotech firm in late-stage clinical trials
  • Raised $150+ million from public and private equity markets and high net worth investors
  • MBA/JD and BA from the University of Virginia

Peter Barton Hutt, JD
Director

  • Senior Counsel, Covington & Burling LLP, specializing in Food and Drug Law
  • Former General Counsel to the Food and Drug Administration
  • Served on Board of Directors for 30+ biotechnology companies

Co-Founders

Benjamin Gaston, MD

Member, Scientific Advisory Board

  • Co-Inventor of the novel platform technology
  • NIH and foundation funded for platform technology development
  • Professor of Pediatrics and Vice Chair for Translational Research, Herman B Wells Center, Indiana University School of Medicine

James Bates, MD/PhD

Chief Medical Officer

  • Co-Inventor of the novel platform technology
  • Former practicing anesthesiologist, University of Iowa
  • PhD, Biochemistry/Molecular Biology, University of California-Santa Barbara
  • MD, Medicine, University of Miami School of Medicine

Stephen Lewis, PhD

Member, Scientific Advisory Board

  • Co-Inventor of the novel platform technology
  • NIH and foundation funded for platform technology development
  • Professor, Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, Case Western Reserve University School of Medicine